Verition Fund Management’s 89bio ETNB Stock Holding History

Verition Fund Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-112,398	Closed	-$1.65M	–	3630
2025 Q3	$1.65M	Sell	112,398 -8,764	-7%	-$89.3K	0.01%	2132
2025 Q2	$1.19M	Buy	+121,162	New	+$1M	0.01%	2345
2024 Q3	–	Sell	-20,788	Closed	-$167K	–	3277
2024 Q2	$167K	Buy	+20,788	New	+$186K	﹤0.01%	2651
2023 Q2	–	Sell	-32,665	Closed	-$497K	–	2297
2023 Q1	$497K	Buy	+32,665	New	+$426K	0.01%	1239
2021 Q2	–	Sell	-106,731	Closed	-$2.53M	–	1959
2021 Q1	$2.53M	Buy	+106,731	New	+$2.46M	0.03%	359

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Verition Fund Management's ETNB Position: Q4 2025 in Review

Verition Fund Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 112,398 shares — an estimated $1.65M sold.

Verition Fund Management first reported a position in ETNB in Q1 2021 and held it in 5 quarters. The position peaked at $2.53M in Q1 2021. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Verition Fund Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Verition Fund Management sold 112,398 89bio shares in Q4 2025, an estimated $1.65M.
Verition Fund Management first reported a position in 89bio in Q1 2021 and held it in 5 quarters.
Verition Fund Management's 89bio position peaked at $2.53M in Q1 2021.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.